Todisco Joseph 4
4 · CorMedix Inc. · Filed Jan 20, 2026
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Todisco Joseph
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
[F1]2026-01-12$7.15/sh−17,417$124,532→ 492,079 total - Exercise/Conversion
Common Stock
[F2]2026-01-16$3.38/sh+29,585$99,997→ 521,664 total - Tax Payment
Common Stock
2026-01-17$6.78/sh−22,665$153,669→ 498,999 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
[F3]2026-01-16−29,585→ 411,245 totalExercise: $3.38Exp: 2032-05-09→ Common Stock (29,585 underlying)
Footnotes (3)
- [F1]This transaction is being reported late due to an inadvertent administrative error.
- [F2]The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.
- [F3]These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact|2026-01-20